1. Empagliflozin in heart failure with preserved ejection fraction: decoding its molecular mechanism of action using artificial intelligence. (14th October 2021) Authors: Iborra Egea, O; Spitaleri, G; Domingo, M; Revuelta Lopez, E; Codina, P; Cediel, G; Santiago Vacas, E; Cserkoova, A; Pascual Figal, D; Nunez, J; Lupon, J; Bayes Genis, A Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mechanisms of cardiac protection by pirfenidone in the post-myocardial infarction setting. (14th October 2021) Authors: Aimo, A; Iborra Egea, O; Bayes-Genis, A; Galvez-Monton, C; Burchielli, S; Passino, C; Emdin, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Overlapping effects of miR-21 inhibition and drugs for idiopathic pulmonary fibrosis in the post-myocardial infarction setting. (14th October 2021) Authors: Aimo, A; Iborra Egea, O; Passino, C; Emdin, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rationale for CDR132L, an antisense inhibitor of miR-132, for a novel therapy for ventricular remodelling after myocardial infarction. (14th October 2021) Authors: Aimo, A; Iborra Egea, O; Bayes-Genis, A; Passino, C; Emdin, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗